If you are wondering whether Stryker at around $351 a share is still a smart buy, or if the best days are already priced in, ...

Stryker (SYK) just reshuffled its leadership deck, naming long time insider Spencer Stiles as future President and COO while ...

Stryker Corporation (NYSE:SYK) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio. On ...

Stryker SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism. Shares of this ...

Over the past six months, Stryker’s shares (currently trading at $350.50) have posted a disappointing 9% loss, well below the ...

Stryker continues to generate solid growth, despite a challenging demand environment, with Mako, Pangea, and the Inari acquisition driving growth. Stryker's margins should trend higher as it scales ...

Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial ...

Stryker Corp. closed 9.73% below its 52-week high of $406.19, which the company achieved on January 28th.

Stryker (NYSE: SYK), the medical devices powerhouse, has recently launched its Sync Badge—a hands-free, wearable communication device designed to enhance collaboration among healthcare teams. This new ...

Needham upgrades Stryker Corp to Buy, sets $392 target, citing new product launches and strong capital equipment backlog. Analyst expects Stryker's margin improvement and increased M&A activity to ...